EPROSARTAN MESYLATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Eprosartan Mesylate, and what generic alternatives are available?
Eprosartan Mesylate is a drug marketed by Mylan Pharms Inc and is included in one NDA.
The generic ingredient in EPROSARTAN MESYLATE is eprosartan mesylate. There are eleven drug master file entries for this compound. Additional details are available on the eprosartan mesylate profile page.
Summary for EPROSARTAN MESYLATE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 77 |
| Clinical Trials: | 1 |
| Patent Applications: | 1,453 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | EPROSARTAN MESYLATE at DailyMed |
Recent Clinical Trials for EPROSARTAN MESYLATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Abbott | Phase 3 |
| author! et al. BV | Phase 3 |
| Synexus | Phase 3 |
Anatomical Therapeutic Chemical (ATC) Classes for EPROSARTAN MESYLATE
Paragraph IV (Patent) Challenges for EPROSARTAN MESYLATE
| Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
|---|---|---|---|---|---|---|
| TEVETEN | Tablets | eprosartan mesylate | 400 mg and 600 mg | 020738 | 1 | 2010-05-10 |
US Patents and Regulatory Information for EPROSARTAN MESYLATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan Pharms Inc | EPROSARTAN MESYLATE | eprosartan mesylate | TABLET;ORAL | 202012-001 | Nov 16, 2011 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Mylan Pharms Inc | EPROSARTAN MESYLATE | eprosartan mesylate | TABLET;ORAL | 202012-002 | Nov 16, 2011 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
